Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Clinical trial NCT00003466 · COMPLETED

Trial details

NCT number: NCT00003466
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1998-03-01
Primary completion: 2005-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.